Page last updated: 2024-10-21

urea and Tauopathies

urea has been researched along with Tauopathies in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.

Research Excerpts

ExcerptRelevanceReference
"The tauopathies are a group of disorders characterised by aggregation of the microtubule-associated protein tau and include Alzheimer's disease (AD) and the fronto-temporal dementias (FTD)."1.32GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. ( Asuni, AA; Berg, S; Bhat, R; Drummond, JA; Jukes, JP; Lovestone, S; MacKay, D; Mears, A; Mildren, P; Mudher, A; Newman, TA; Shepherd, D; Squire, A, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mudher, A1
Shepherd, D1
Newman, TA1
Mildren, P1
Jukes, JP1
Squire, A1
Mears, A1
Drummond, JA1
Berg, S1
MacKay, D1
Asuni, AA1
Bhat, R1
Lovestone, S1

Other Studies

1 other study available for urea and Tauopathies

ArticleYear
GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila.
    Molecular psychiatry, 2004, Volume: 9, Issue:5

    Topics: Animals; Axonal Transport; Axons; Drosophila melanogaster; Drosophila Proteins; Enzyme Inhibitors; G

2004